Advanced search
Publication Cover
Expert Review of Neurotherapeutics Volume 22, 2022 - Issue 5
Submit an article Journal homepage
456
Views
1
CrossRef citations to date
0
Altmetric
Drug profile

Olanzapine-samidorphan combination tablets for the treatment of schizophrenia and bipolar I disorder - what is it, and will it be used?

Justin Fadena Department of Psychiatry, Lewis Katz School of Medicine at Temple University, Philadelphia, PAUSACorrespondence[email protected]
View further author information
,
Ryan Serdenesa Department of Psychiatry, Lewis Katz School of Medicine at Temple University, Philadelphia, PAUSAView further author information
&
Leslie Citromeb Department of Psychiatry, New York Medical College, Valhalla, NY, USAView further author information
Pages 365-376 | Received 31 Jan 2022, Accepted 29 Mar 2022, Published online: 13 Apr 2022

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.